Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh‐Ming Liou, Ming‐Shiang Wu, Jiing‐Chyuan Luo et al.|The Lancet|2012Cited by 268
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh‐Ming Liou, Ming‐Shiang Wu, Emad El‐Omar et al.|The Lancet|2016Cited by 202